Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Table)

v3.22.1
Commitments and Contingencies (Table)
12 Months Ended
Dec. 31, 2021
Commitments And Contingencies Disclosure [Abstract]  
Schedule of Milestone Payment

As consideration for its services, Sphaera has received a fixed fee of $160,000 and is entitled to the following milestone payments upon achievement of specified milestones:

 

Milestone Event

 

Payment

 

First dosing of patient in US Phase 1 trial

 

$

250,000

 

US Phase 1 trial completion with endpoints met

 

 

500,000

 

US Phase 2 trial completion with endpoints met

 

 

875,000

 

FDA Approval

 

 

4,000,000

 

Total potential milestone payments

 

$

5,625,000